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department at midnight with slurred speech, muscle
weakness, and bilateral lower limb paralysis. His weight,
height, blood pressure, and pulse rate were 79 kg, 1.67 m,
146/64 mmHg, and 83 beats/min, respectively. He had no
fever, diarrhea, or vomiting. The patient’s hemogram was
normal, but biochemical analyses (Table 1) showed low
levels of potassium (1.56 meq/L) and phosphate (2.0 mg/dL)
and an elevated level of creatine phosphokinase (243 U/L).
The levels of serum cortisol, renin, and aldosterone were
within the normal ranges and thyroid function test showed
hyperthyroidism (Table 1). However, clinical signs such as
tachycardia, goiter, ophthalmopathy, and tremor were not
observed.
The serum potassium level returned to 3.14 meq/L after
infusion of 150 meq of potassium chloride in about 20 h,
and the patient gradually regained his muscle power.
Without administration of any supplements, his serum
phosphate level returned to normal. Further, his serum
creatine phosphokinase level also returned to normal. The* Corresponding author. Department of Endocrinology and
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doi:10.1016/j.jfma.2011.11.032ultrasound examination of the thyroid revealed diffuse
goiter.
Our patient had been diagnosed with hyperthyroidism 48
years ago. He was successfully treated with radioiodine
therapy soon after the diagnosis. Before this episode of
acute paralysis, he experienced insomnia, anxiety, and
weight loss of 9 kg (from 87 kg to 78 kg) for half a year;
these may have been symptoms of recurrent hyperthy-
roidism. However, he visited a psychiatry clinic instead
where he was prescribed hypnotics for treating insomnia. In
addition, the patient had had diabetes mellitus for 30
years. He had received insulin therapy (15 units of insulin
glargine at bedtime) along with oral antidiabetes medica-
tion 5 months prior to this episode of acute paralysis attack.
The patient was diagnosed with thyrotoxic periodic
paralysis (TPP), which is characterized by muscle paralysis
and hypokalemia. TPP may be the presenting feature of
hyperthyroidism or may occur during recurrent hyperthy-
roidism.1 Very severe hypokalemia may lead to total
paralysis, including paralysis of the respiratory, bulbar, and
cranial muscles.1,2 In our patient, the slurred speech
completely resolved after correction of hypokalemia; this
suggests that slurring of speech might have been associated
with TPP. The low level of phosphate usually returns to
normal without any supplementation when the patient
recovers from the weakness.1 The majority of TPP cases& Formosan Medical Association. All rights reserved.
Table 1 Laboratory findings obtained at the time of
diagnosis of thyrotoxic periodic paralysis.
Laboratory test At diagnosis Normal range
Blood biochemistry
Plasma glucose 169 mg/dL (<140)
Potassium 1.56 meq/L (3.0e4.8)
Phosphate 2.0 mg/dL (2.4e4.7)





Osmolarity (U) 453 mosm/KgH2O (50e1400)
Potassium (U) 15.68 meq/L (25e125)
Hormonal data
Free T4 1.99 ng/dL (0.89e1.76)
TSH 0.043 mIU/mL (0.35e5.50)
TBII 37.6% (-):<15%, (þ):>15%
Anti-TPO Ab 2.8 IU/mL (<12)
Renin 27.3 pg/mL (3.0e28.4)
Aldosterone 55.3 pg/mL (29e162)
Cortisol 10.50 mg/dL (4.3e22.4)
TSHZ thyroid-stimulating hormone; TBIIZ thyrotropin binding
inhibiting immunoglobulin; Anti-TPO AbZ Antithyroid peroxi-
dase antibody; T4Z thyroxine.
TPP in an old diabetes patient 351appear to be sporadic. Our patient is among the oldest TPP
patients reported in the literature.
Insulin resistance with compensatory hyperinsulinemia
is suspected to play a role in the pathogenesis of TPP.3
Injection of insulin and carbohydrates can induce para-
lytic attacks in hyperthyroid patients with TPP history.4
However, it is unclear if insulin treatment administered to
a diabetes patient with hyperthyroidism plays a role in
triggering TPP attacks.
In conclusion, the possibility of TPP should be considered
for Asian patients of any age presenting with acute lower
limb paralysis. More clinical studies are needed to under-
stand whether insulin treatment is related to TPP in a dia-
betes patient with hyperthyroidism.References
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